'%20cy='5.2227'%20cx='-20.033'%20r='3.5391'%20fill='%23ffffff'/%3e%3c/g%3e%3cg%20opacity='.9'%3e%3ccircle%20fill-rule='evenodd'%20cx='-2.5033'%20transform='matrix(-.76604%20.64279%20.64279%20.76604%200%200)'%20cy='13.387'%20r='3.5391'%20stroke-width='0'%20fill='%23ffffff'/%3e%3c/g%3e%3cg%20opacity='.8'%3e%3ccircle%20stroke-width='0'%20fill-rule='evenodd'%20transform='matrix(-.17365%20.98481%20.98481%20.17365%200%200)'%20cy='8.3722'%20cx='16.173'%20r='3.5391'%20fill='%23ffffff'/%3e%3c/g%3e%3cg%20opacity='.7'%3e%3ccircle%20fill-rule='evenodd'%20cx='27.257'%20transform='matrix(.5%20.86603%20.86603%20-.5%200%200)'%20cy='-7.474'%20r='3.5391'%20stroke-width='0'%20fill='%23ffffff'/%3e%3c/g%3e%3cg%20opacity='.6'%3e%3ccircle%20stroke-width='0'%20fill-rule='evenodd'%20transform='matrix(.93969%20.34202%20.34202%20-.93969%200%200)'%20cy='-26.738'%20cx='25.562'%20r='3.5391'%20fill='%23ffffff'/%3e%3c/g%3e%3cg%20opacity='.5'%3e%3ccircle%20fill-rule='evenodd'%20cx='11.881'%20transform='matrix(.93969%20-.34202%20-.34202%20-.93969%200%200)'%20cy='-40.405'%20r='3.5391'%20stroke-width='0'%20fill='%23ffffff'/%3e%3c/g%3e%3cg%20opacity='.4'%3e%3ccircle%20stroke-width='0'%20fill-rule='evenodd'%20transform='matrix(.5%20-.86603%20-.86603%20-.5%200%200)'%20cy='-42.081'%20cx='-7.3838'%20r='3.5391'%20fill='%23ffffff'/%3e%3c/g%3e%3cg%20opacity='.3'%3e%3ccircle%20fill-rule='evenodd'%20cx='-23.219'%20transform='matrix(-.17365%20-.98481%20-.98481%20.17365%200%200)'%20cy='-30.981'%20r='3.5391'%20stroke-width='0'%20fill='%23ffffff'/%3e%3c/g%3e%3cg%20opacity='.2'%3e%3ccircle%20stroke-width='0'%20fill-rule='evenodd'%20transform='matrix(-.76604%20-.64279%20-.64279%20.76604%200%200)'%20cy='-12.299'%20cx='-28.215'%20r='3.5391'%20fill='%23ffffff'/%3e%3c/g%3e%3c/svg%3e){kind=small}
Home
Current Topics Nonclinical Drug Development: Volume 1
Loading Inventory...
Barnes and Noble
Current Topics Nonclinical Drug Development: Volume 1
Current price: $230.00
Barnes and Noble
Current Topics Nonclinical Drug Development: Volume 1
Current price: $230.00
Loading Inventory...
Size: Hardcover
*Product Information may vary - to confirm product availability, pricing, and additional information please contact Barnes and Noble
The inaugural volume in the
Current Topics in Nonclinical Drug Development
Series explores the critical issues and current topics in nonclinical drug development. This first volume covers individual topics and strategies in drug development from compound characterization to drug registration. Written by a variety of experts in the field, recent and rapid advances in technologies and associated changes in regulatory guidance are discussed.
Additional features include:
Deals with day-to-day issues in study design, evaluation of findings, and presentation of data.
Explains new approaches in the development of medical devices.
Includes dedicated chapters on the use of bioinformatics in drug development.
Addresses strategies for photosafety testing of drugs.
Current Topics in Nonclinical Drug Development, Volume I will aid toxicologists, toxicologic pathologists, consultants, regulators, Study Directors, and nonclinical scientists dealing with day-to-day issues in study design, evaluation of findings, and presentation of data. In addition, the book will be a valuable reference for academicians and graduate students pursuing research related to nonclinical drug development.
Current Topics in Nonclinical Drug Development
Series explores the critical issues and current topics in nonclinical drug development. This first volume covers individual topics and strategies in drug development from compound characterization to drug registration. Written by a variety of experts in the field, recent and rapid advances in technologies and associated changes in regulatory guidance are discussed.
Additional features include:
Deals with day-to-day issues in study design, evaluation of findings, and presentation of data.
Explains new approaches in the development of medical devices.
Includes dedicated chapters on the use of bioinformatics in drug development.
Addresses strategies for photosafety testing of drugs.
Current Topics in Nonclinical Drug Development, Volume I will aid toxicologists, toxicologic pathologists, consultants, regulators, Study Directors, and nonclinical scientists dealing with day-to-day issues in study design, evaluation of findings, and presentation of data. In addition, the book will be a valuable reference for academicians and graduate students pursuing research related to nonclinical drug development.
You May Also Like
More About Barnes and Noble at MarketFair Shoppes
Barnes & Noble does business -- big business -- by the book. As the #1 bookseller in the US, it operates about 720 Barnes & Noble superstores (selling books, music, movies, and gifts) throughout all 50 US states and Washington, DC. The stores are typically 10,000 to 60,000 sq. ft. and stock between 60,000 and 200,000 book titles. Many of its locations contain Starbucks cafes, as well as music departments that carry more than 30,000 titles.
Store Info
